Please enable JS

Popsi Cube

Pan European Clinical Contract Research Organisation (CRO), that offers to their partners a complete outsourcing of their clinical trials from phase I to phase IV by integrating the value creation chain of medical product development activity.

The origin of Popsi Cube is a convergence between a solid clinical process and effective IT tools. A CRO with integrated tools to address the entire clinical research functional scope. A successful project management requires top quality human resources but also a set of tools supporting a simple, pertinent and effective decision process.

 

Learn more: www.popsicube.com

A LEADING POSITION AND
AN INTERNATIONAL DEPLOYMENT

64 +

countries
involved

20 000 +

investigational
Centres

3 million +

patients
in database

50 000 +

users
worlwide

telemedicine technologies earth

LATEST NEWSOUR NEWS >

telemedecine technologies news

CDISC Presents: TMF Reference Model General Meeting – Webinar

September 2, 2024

17 September 2024 – 11am – 12:30pm EDT Register for this webinar to receive essential updates on the CDISC transition and learn about new regulations and initiatives impacting Trial Master Files (TMF). Don’t miss this opportunity to stay informed about the latest industry standards and practices. Read more and register: https://cdisc.zoom.us/webinar/register/WN_WqNz9_hiRVihH_pe1IEurA#/registration

READ MORE
telemedecine technologies news

Enabling Clinical Trial Innovation Through AI Regulation at FDA

September 2, 2024

Med City News Innovation is not just a luxury but a necessity in the realm of clinical trials, particularly as we strive to accelerate drug development. Yet, the slow pace of innovation within the U.S. clinical trials system has impeded progress, leaving many stakeholders frustrated. U.S. Food and Drug Administration (FDA) resource limitations cause the […]

READ MORE
telemedecine technologies news

A Holistic Approach to Safeguard Data Integrity in Biopharma Manufacturing

September 2, 2024

International Biopharma Data integrity is critical in Biopharma manufacturing yet is often difficult to achieve due to complex regulatory requirements and legacy data management systems, among the many factors. Furthermore, issues such as data accuracy, completeness and security impact product quality, regulatory compliance and ultimately patient safety. Addressing all these challenges demands a multifaceted approach […]

READ MORE